首页 | 本学科首页   官方微博 | 高级检索  
     

糖皮质激素联合聚桂醇治疗增生期体表草莓状毛细血管瘤的疗效及对Bcl-2、Bax mRNA的影响
引用本文:王淼,庞文帅,马建苏,王伟,周丽霞. 糖皮质激素联合聚桂醇治疗增生期体表草莓状毛细血管瘤的疗效及对Bcl-2、Bax mRNA的影响[J]. 儿科药学杂志, 2021, 27(4): 30-34
作者姓名:王淼  庞文帅  马建苏  王伟  周丽霞
作者单位:邢台市人民医院,河北邢台054000;河北省民政总医院,河北邢台054000
摘    要:目的:探讨糖皮质激素联合聚桂醇治疗增生期体表草莓状毛细血管瘤患者的临床疗效及对组织Bcl-2、Bax mRNA的影响.方法:选取我院2015年5月至2017年10月收治的120例增生期体表草莓状毛细血管瘤患儿120例,依据随机数表法分为观察组和对照组各60例.对照组接受常规糖皮质激素治疗,观察组给予聚桂醇+糖皮质激素治...

关 键 词:糖皮质激素  聚桂醇  Bcl-2  Bax  草莓状毛细血管瘤

Efficacy of Glucocorticoid Combined with lauromacrogol in the Treatment of Strawberry Capillary Hemangioma in Hyperplastic Phase and Its Effects on Bcl-2 and Bax mRNA
Wang Miao,Pang Wenshuai,Ma Jiansu,Wang Wei,Zhou Lixia. Efficacy of Glucocorticoid Combined with lauromacrogol in the Treatment of Strawberry Capillary Hemangioma in Hyperplastic Phase and Its Effects on Bcl-2 and Bax mRNA[J]. Journal of Pediatric Pharmacy, 2021, 27(4): 30-34
Authors:Wang Miao  Pang Wenshuai  Ma Jiansu  Wang Wei  Zhou Lixia
Affiliation:(Xingtai People’s Hospital,Hebei Xingtai 054000,China;Hebei General Hospital of Civil Affairs,Hebei Xingtai 054000,China)
Abstract:[Abstract] Objective: To probe into the clinical efficacy of glucocorticoid combined with lauromacrogol in the treatment of strawberry capillary hemangioma in hyperplastic phase and its effects on Bcl-2 and Bax mRNA. Methods: Totally 120 children with strawberry capillary hemangioma in hyperplastic phase admitted into our hospital from May 2015 to Oct. 2017 were extracted to be divided into the observation group and the control group via the random number table, with 60 cases in each group. The control group was treated with conventional glucocorticoid, while the observation group received lauromacrogol combined with glucocorticoid. The efficacy and adverse drug reactions, expression of Bcl-2 and Bax mRNA, serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) before and after treatment of two groups were compared. Results: The total effective rate in the observation group 88.33% was higher than that in the control group 73.33%, the difference was statistically significant (P<0.05). After treatment, serum VEGF and bFGF decreased in both groups, and the observation group was significantly lower than the control group (P<0.05). The expression of Bcl-2 mRNA decreased, and the expression of Bax mRNA increased. The expression of Bcl-2 mRNA in the observation group was lower than that in the control group, and the expression of Bax mRNA was higher than that in the control group (P<0.05). Adverse drug reactions were mainly local swelling, local ulcers, pigmentation, central obesity, and hypertension, and there was no statistically significant difference (P>0.05). Conclusion: The clinical efficacy of glucocorticoid combined with lauromacrogol in the treatment of strawberry capillary hemangioma in hyperplastic phase is significant, which can effectively reduce the expression of Bcl-2 mRNA and promote the expression of Bax mRNA, so as to accelerate the apoptosis of hemangioma cells and improve the efficacy.
Keywords:glucocorticoid   lauromacrogol   Bcl-2   Bax   strawberry capillary hemangioma
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《儿科药学杂志》浏览原始摘要信息
点击此处可从《儿科药学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号